ARCH Venture Partners
Venture capital firm investing in early-stage science and technology companies.
Active
VC 🇺🇸 United States · United States ·
Since 1986
Deal flow
$1.1B
9 rounds
Unicorns
0
≥ $1B valuation
Founded
1986
40 yrs
Latest
Oct 2026
Oratomic
Venture capital firm investing in early-stage science and technology companies.
$278M
$475M
2
'25
1
'26
Paradigm Health
AI research platform making clinical trials part of routine patient care
Treeline Biosciences
Computational and experimental drug discovery for hard-to-drug cancer targets
Aira
On-demand visual interpreting that makes the world accessible for blind and low-vision people
Ollin Biosciences
Biotech advancing best-in-class bispecific antibody therapies for eye disease, using AI and
Oratomic
Building the world's first fault-tolerant quantum computers using ultra-efficient error correction.